PROFILE
KAMIGAKI Takashi, M.D., Ph.D.
Department of Next Generation Cell and Immunotherapy
Short Biography
- 1987
- M.D. Kobe University School of Medicine
- 1987
- Resident, 1st Dept Surgery, Kobe University Hospital
- 1989
- Resident, Surgery, Yodogawa Christian Hospital
- 1995
- Ph.D. Kobe University Graduate School of Medicine
- 1996
- Faculty Staff, Surgery, National Kobe Hospital
- 1998
- Faculty Staff, 1st Dept Surgery, Kobe University Hospital
- 2003
- Assistant Professor, Gastrointestinal Surgery, Kobe University Hospital
- 2006
- Associate Professor, Gastrointestinal Surgery, Kobe University Hospital
- 2010
- Director, Seta Clinic Osaka
- 2010-Present
- Visiting Professor, Kobe University
- 2011-Present
- Director, Clinical Research and Trial Center, Seta Clinic Group
- 2012-2015
- Director, Seta Clin Shin-Yokohama
- 2017-Present
- Professor, Next Generation of Cell and Immunotherapy, Juntendo University
Graduate School of Medicine
Keywords
- Immunotherapy
- Dendritic Cell
- TIL, TCR-T and CAR-T
- Neoantigen
Main Research Topics and Interests
- Comprehensive Immunotherapy
- Glycolysis Control of T Cells
- Engineered T Cells and Dendritic Cells
- Genome-based Precision Immunotherapy
Publications (in English)
- Original Articles: 75
- Review Articles: 3
- h-index: 17 (Web of Science)
- Sum of Times Cited: 905 (Web of Science)
Recent Main Publications
- Takimoto R, Kamigaki T, Okada S, Ibe H, Oguma E, Goto S. Prognostic Factors for
Advanced/Recurrent Breast Cancer Treated with Immune-cell Therapy. Anticancer Res.
2021 41(8):4133-4141.
- Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Kamigaki T, Goto S, Takahara M, Goto H.
Comprehensive Immunotherapy Combined with Intratumoral Injection of
Zoledronate-pulsed Dendritic Cells, Intravenous Adoptive Activated T Lymphocyte and
Gemcitabine in Unresectable Locally Advanced Pancreatic Carcinoma: A Phase I/II
Trial. Oncotarget. 2017 9(2):2838-2847.
-
Inoo K, Inagaki R, Fujiwara K, Sasawatari S, Kamigaki T, Nakagawa S, Okada N.
Immunological Quality and Performance of Tumor Vessel-targeting CAR-T Cells Prepared
by mRNA-EP for Clinical Research. Mol Ther Oncolytics. 2016 16:16024
- More
Link
